FBN1 and aortic aneurysm: Most patients with MFS will ultimately develop cardiovascular outcomes (aortic aneurysm, valve prolapse as well as LV dysfunction, etc.)and might further progress into aortic dissection, owing to the clinical variability in FBN1 gene mutations.